ST. PAUL, Minn.--(BUSINESS WIRE)--Restore Medical, Inc. (NASDAQ:REST), developer of the innovative Pillar® Palatal Implant System – a simple, minimally-invasive treatment to help individuals suffering from snoring and mild-to-moderate obstructive sleep apnea (OSA) – today announced the presentation of positive results from the first U.S. multi-center Level 1 evidence based medicine clinical study of its Pillar palatal implants, which affirmed the efficacy observed in earlier studies in the treatment of mild to moderate OSA. David Steward, M.D., Associate Professor and Director of Clinical Studies, University of Cincinnati Medical Center, and his colleagues, presented their findings, “Palate Implants for OSA: Multi-Institution, Randomized, Placebo Controlled Study,” yesterday at the 111th Annual Meeting & OTO EXPO of the American Academy of Otolaryngology - Head and Neck Surgery Foundation in Washington D.C.
